Emma Whitelaw ECR Publication Award
Recent Posts
Spotlight on: Melanie Eckersley-Maslin 25 November 2022
Spotlight on: Jessamy Tiffen 25 July 2022
ECR Spotlight on: Alex Woodworth 16 July 2022
Epigenetics 2022: Four weeks left for poster abstract submissions! 15 July 2022
Emma Whitelaw ECR Publication Award 30 June 2022
Epigenetics 2022 – Meet the speakers 17 June 2022
ECR Spotlight on: Kate Giles 31 May 2022
Spotlight on: Luciano Martelotto 30 May 2022
Epigenetics 2022 speakers announced 20 April 2022
Spotlight on: Hamish King 18 April 2022
ECR Spotlight on: William Schierding 6 April 2022
Spotlight on: Louise Bicknell 14 March 2022
Categories
News (57)
Opportunities (3)
Publications (7)
Spotlight on … (16)
World epi news (2)
Archived news
2022 (12)
2021 (9)
2020 (9)
2019 (1)
2018 (6)
2017 (6)
2016 (6)
2015 (17)
2014 (1)
by AEpiA | Jun 30, 2022 | News, Opportunities
To all Early Career Researchers,
The AEpiA Committee would like to invite you to apply for the new Emma Whitelaw ECR Publication Award.
This award has a value of $1000 and is open to post-doctoral ECRs (less than 5 years post-PhD) and PhD/Masters/Honours students. It will be awarded to the best first or senior author peer-reviewed primary research paper (not a review) published in press or in full between 1st Aug 2020 and 31st July 2022.
The award will be announced at the Epigenetics 2022 conference (11th-14th September, Kingscliff, NSW).
The application form and guidelines can be downloaded here. This file contains detailed information on the Award and selection process.
Applications are open from the 11th July 2022 and close on the 7th August 2022.
We would be happy for you to spread the word to anyone else you think may be interested in the Award.
If you have any questions please contact ECR@epialliance.org.au
We look forward to seeing you at Epigenetics 2022.
About Emma Whitelaw
Professor Emma Whitelaw has contributed more than 20 years of research to the field of epigenetics. Her research pioneered the study of epigenetic inheritance, establishing that in some cases epigenetic states were inheritable across generations.
Prof Whitelaw also established a valuable and still currently used mouse model for finding epigenetic reprogramming genes. Her work then transitioned to the study of complex gene-environment interactions in human disease, enabling the identification of new disease risk target genes for drug discovery.
In 2008 Prof Whitelaw was awarded a prestigious Australia Fellowship, and in 2010 she was presented with the Australia and New Zealand Society for Cell and Developmental Biology President’s Medal. In 2011 she received the Jubilee Medal from the International Union of Biochemistry and Molecular Biology for work on the transgenerational inheritance of epigenetic marks and became a Fellow of the Australian Academy of Science.